| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,006 | 0,020 | 17:49 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | Preveceutical Medical Inc: Preveceutical closes first tranche of financing | 3 | Stockwatch | ||
| 22.10. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 515 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased announce that, further... ► Artikel lesen | |
| 29.09. | Preveceutical Medical Inc: Preveceutical Medical arranges $600,000 financing | 5 | Stockwatch | ||
| 28.09. | PreveCeutical launches private placement to raise up to $600,000 | 1 | Seeking Alpha | ||
| 28.09. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 416 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered... ► Artikel lesen | |
| 04.08. | PreveCeutical Medical Inc.: PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement | 685 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 28.07. | Preveceutical Medical Inc: Preveceutical Medical closes third tranche of financing | 3 | Stockwatch | ||
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.07. | PreveCeutical Medical Inc.: PreveCeutical Closes Third Tranche of Non-Brokered Private Placement | 500 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 13.06. | Preveceutical Medical Inc: Preveceutical closes $245K second tranche of placement | 4 | Stockwatch | ||
| 12.06. | PreveCeutical Medical Inc.: PreveCeutical Closes Second Tranche of Non-Brokered Private Placement | 1.000 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 08.06. | Preveceutical Medical Inc: Preveceutical investment BioGene names Howton director | 6 | Stockwatch | ||
| 08.06. | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors | 762 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative... ► Artikel lesen | |
| 20.05. | PreveCeutical Medical Inc.: PreveCeutical Announces Extension of Non-Brokered Private Placement | 829 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 12.05. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 648 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 22.04. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 614 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 01.04. | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | 723 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen | |
| 30.03. | PreveCeutical Medical Inc.: PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director | 609 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that... ► Artikel lesen | |
| 25.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology | 781 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen | |
| 09.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents | 528 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it... ► Artikel lesen | |
| 04.12.25 | PreveCeutical Medical Inc.: PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology | 587 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,96 | +0,62 % | Fresenius verkauft weitere FMC-Aktien und reduziert Beteiligung auf 20 Prozent | Fresenius setzt den Rückzug aus seiner Beteiligung am Dialysespezialisten Fresenius Medical Care (FMC) fort. Der Gesundheitskonzern will rund 13,4 Millionen FMC-Aktien verkaufen, was etwa 5 Prozent... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,050 | +1,39 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.11.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,070 | +0,34 % | Aktie zieht an!: Siemens liefert und legt nach, die Strategie überzeugt wirft Fragen auf | © Foto: Joko - JokoSiemens meldet Rekordzahlen und hebt die Mittelfristziele an. Anleger bleiben trotzdem skeptisch, denn die neue Konzernstrategie gilt vielen noch als zu unscharf Enthaltene Werte:... ► Artikel lesen | |
| INTUITIVE SURGICAL | 399,30 | -0,78 % | Where Will Intuitive Surgical Be in 10 Years? Hint: Its da Vinci 5 Installed Base Just Topped 2,000 | ||
| DRAEGERWERK | 111,20 | +0,90 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 93,98 | +0,69 % | Medtronic To Acquire Contego Medical For $380 Mln | WASHINGTON (dpa-AFX) - Medical devices maker Medtronic Plc (2M6.DE, MDT) announced on Monday that it has agreed to acquire privately held Contego Medical, expanding its portfolio of carotid... ► Artikel lesen | |
| THERMO FISHER | 633,40 | -0,28 % | 65% der untersuchten FDA-Rückschläge betrafen Produktionsstätten: Die unsichtbare Hürde für Lonza, Thermo Fisher und NeuroThera | ||
| TELADOC HEALTH | 7,986 | +0,08 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,065 | -6,05 % | Sernova Biotherapeutics: 11,2 Millionen für die Fusion - wie viel Rückenwind bleibt? | ||
| FAMICORD | 2,350 | +0,82 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2026 | Das Instrument E36 CY0101162119 SED ENERGY HLDGS. DL 0,2 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2026 und ex Kapitalmassnahme am 09.11.2026 The instrument E36 CY0101162119 SED ENERGY HLDGS.... ► Artikel lesen | |
| OTTOBOCK | 39,150 | +2,17 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| HEARTFLOW | 48,540 | +0,43 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| BRIGHTSPRING HEALTH SERVICES | 71,57 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| STARLING ONCOLOGY INSTITUTE | 3,620 | 0,00 % | NSE - Starling Oncology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| PRIVIA HEALTH GROUP | 24,875 | +1,28 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |